The DOI matches its Crossref record.
Tachykinin antagonists
Abstract
The discovery of nonpeptide antagonists of the tachykinin peptides substance P, neurokinin A, and neurokinin B has greatly accelerated pharmacological characterization of the role of these peptides and their receptors (NK-1, NK-2, and NK-3) in the central nervous system (CNS). The extensive structural diversity of the nonpeptide tachykinin antagonists offers considerable potential for therapeutic agents targeting this system, and includes NK-1 antagonists such as: I. the quinuclidine amines (CP-96,345) and related ethers, 2. the piperidine amines (CP-99,994) and related ethers and acyclic variants, 3. the isoindolines such as RP 67,580 and RPR 100,893, 4. the 2-benzylpiperidines CGP-47,899 and CGP 49,823, 5. the peptide-derived FK-888, and 6. SR-140,333, as well as NK-2 antagonists such as SR-48,968, and GR-159,897, and NK-3 antagonists such as PD- 157,652 and SR-142,801. Important new pharmacological insights facilitated by these compounds indicate a role for tachykinin peptides in control of dopamine function in the CNS, emesis, pain, and neurogenic inflammation. These compounds have also enabled characterization of the nonpeptide antagonist binding site on the NK-1 receptor, providing insight on the mechanism of receptor antagonism to help in the design of new compounds. Hence the nonpeptide tachykinin antagonists continue to play an important role in characterizing biochemical, pharmacological, and potential therapeutic aspects of the tachykinin peptides.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Holzer, P. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90064-4 · Cited by 1,665
The sensory-efferent function of capsaicin-sensitive sensory neurons
Maggi, C. A., & Meli, A. (1988) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(88)90002-x · Cited by 931
Tachykinin receptors and tachykinin receptor antagonists
Maggi, C. A., Patacchini, R., Rovero, P., & Giachetti, A. (1993) · Journal of Autonomic Pharmacology · doi:10.1111/j.1474-8673.1993.tb00396.x · Cited by 636
May, A., & Goadsby, P. J. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199902000-00001 · Cited by 582
Substance P: a pioneer amongst neuropeptides
Hökfelt, T., Pernow, B., & Wahren, J. (2001) · Journal of Internal Medicine · doi:10.1046/j.0954-6820.2000.00773.x · Cited by 346
Tachykinin receptor types: Classification and membrane signalling mechanisms
Guard, S., & Watson, S. P. (1991) · Neurochemistry International · doi:10.1016/0197-0186(91)90180-l · Cited by 340
Calcitonin gene-related peptide (CGRP): perivascular distribution and vasodilatory effects
Uddman, R., Edvinsson, L., Ekblad, E., Håkanson, R., & Sundler, F. (1986) · Regulatory Peptides · doi:10.1016/0167-0115(86)90071-6 · Cited by 323
Multiple tachykinin binding sites in peripheral tissues and in brain
Lee, C.-M., Campbell, N. J., Williams, B. J., & Iversen, L. L. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90270-0 · Cited by 275
B-Afferents: A fundamental division of the nervous system mediating homeostasis?
Prechtl, J. C., & Powley, T. L. (1990) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00078729 · Cited by 42
Metadata
- Venue
- Expert Opinion on Therapeutic Patents
- Publisher
- Informa Healthcare
- Published
- 1994-07
- Volume
- 4
- Issue
- 7
- Pages
- 859-860
- ISSN
- 1354-3776 (ISSN-L)
- 1744-7674
- OpenAlex
- W4235222786
- Cited by
- 364
- References
- 0
- FWCI
- 5.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.